InvestorsHub Logo
Followers 0
Posts 51
Boards Moderated 0
Alias Born 09/27/2017

Re: Longmoney post# 4650

Monday, 12/11/2017 10:16:22 AM

Monday, December 11, 2017 10:16:22 AM

Post# of 7900
17mln debt is absolutely pittance. Please open any biotech company and look their liabilities. So I have no idea why this point point is being brought up again and again. Unless of course writers of 17mln has ulterior motive as to plant seeds of doubt on new investors who don't know much in investing or trading. Basic comparison will show you that 17mln is not a problem at all.

"Few Years" in Europe. It has not been FEW YEARS. Sehnance was purchased September 2015 and they really started marketing it in 2016 first quarter. Since then they sold 3 pieces in Europe.

FDA clearance will give TRXC more confidence to ramp up sales. FL hospital used Senhance, loved it and bought it. No one buys 1.5mln dollar equipment if it wouldn't benefit them.


More sales are coming! 100mln in cash so 17mln debt got nothing on us. TRXC can pay it off any moment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASXC News